Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 12, Issue 8, Pages 1113-1124
Publisher
Informa Healthcare
Online
2012-07-11
DOI
10.1517/14712598.2012.704014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LONG-TERM EFFECTS OF A BERBERINE BASED NUTRACEUTICAL ON BODY WEIGHT AND INSULIN-SENSITIVITY IN NON DIABETIC HYPERLIPIDAEMIC PATIENTS
- (2013) A. Cicero et al. JOURNAL OF HYPERTENSION
- Modulating gut microbiota as an anti-diabetic mechanism of berberine
- (2013) Junling Han et al. MEDICAL SCIENCE MONITOR
- Standards of Medical Care in Diabetes--2012
- (2011) DIABETES CARE
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
- (2011) David R. Whiting et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway
- (2011) Xi Xie et al. ENDOCRINE JOURNAL
- Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
- (2011) Lian-Jun Xing et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes
- (2011) Naeti Suksomboon et al. JOURNAL OF ETHNOPHARMACOLOGY
- Dose–response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice
- (2011) Ying Guo et al. JOURNAL OF ETHNOPHARMACOLOGY
- Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
- (2011) Xuan Xia et al. PLoS One
- Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
- (2011) Weidong Xie et al. PLoS One
- Anti-cancer natural products isolated from chinese medicinal herbs
- (2011) Wen Tan et al. Chinese Medicine
- Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
- (2010) Tian Lan et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Berberine-induced activation of 5′-adenosine monophosphate–activated protein kinase and glucose transport in rat skeletal muscles
- (2010) Xiao Ma et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study
- (2010) Li Liu et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics
- (2010) Yan Gu et al. TALANTA
- Targeting metabolic syndrome: Candidate natural agents
- (2010) Xuan XIA et al. Journal of Diabetes
- Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational
- (2009) Martin Sénécal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Berberine-induced decline in circulating CD31+/CD42− microparticles is associated with improvement of endothelial function in humans
- (2009) Jie-mei Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats
- (2009) Jiyin Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hepatocyte Nuclear Factor 1α Plays a Critical Role inPCSK9Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
- (2009) Hai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements
- (2009) Hai Li et al. JOURNAL OF LIPID RESEARCH
- Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
- (2009) Hao Zhang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition
- (2009) Weihua Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study
- (2009) F. Affuso et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Berberine decreases PCSK9 expression in HepG2 cells
- (2008) Jamie Cameron et al. ATHEROSCLEROSIS
- Chronic Effects of Berberine on Blood, Liver Glucolipid Metabolism and Liver PPARs Expression in Diabetic Hyperlipidemic Rats
- (2008) Ji Yin Zhou et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis
- (2008) Wei Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Berberine Modifies Cysteine 179 of I B Kinase, Suppresses Nuclear Factor- B-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis
- (2008) M. K. Pandey et al. CANCER RESEARCH
- Berberine-Induced Upregulation of Circulating Endothelial Progenitor Cells Is Related to Nitric Oxide Production in Healthy Subjects
- (2008) Ming-Guo Xu et al. CARDIOLOGY
- Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I: A Mechanism for the Action of Berberine to Activate AMP-Activated Protein Kinase and Improve Insulin Action
- (2008) N. Turner et al. DIABETES
- Berberine Acutely Inhibits Insulin Secretion from β-Cells through 3′,5′-Cyclic Adenosine 5′-Monophosphate Signaling Pathway
- (2008) Libin Zhou et al. ENDOCRINOLOGY
- Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells
- (2008) Kae-Woei Liang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats
- (2008) Shou-Si Lu et al. JOURNAL OF ENDOCRINOLOGY
- Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
- (2008) Erik W. Holy et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Combination of simvastatin with berberine improves the lipid-lowering efficacy
- (2008) Wei-Jia Kong et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
- (2008) Wei-Jia Kong et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
- (2008) Mohsen Imanshahidi et al. PHYTOTHERAPY RESEARCH
- Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity
- (2008) Zhi-Quan Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ
- (2008) Ping Yi WORLD JOURNAL OF GASTROENTEROLOGY
- Traditional Chinese Medicine in Treatment of Metabolic Syndrome
- (2008) Jun Yin et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Berberine improves glucose metabolism through induction of glycolysis
- (2007) Jun Yin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search